NCT00547625 - Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems | Biotech Hunter

Enrollment

275

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

July 31, 2005

Conditions

Prostatic HyperplasiaProstate

Interventions

DRUG

tadalafil

Treatment phase 1 includes 5 mg tadalafil tablet taken by mouth once a day for 6 weeks then treatment phase 2 which includes 20 mg tadalafil tablet taken by mouth once a day for 6 weeks.

DRUG

placebo

Placebo tablet run in followed by placebo treatment period with one tablet taken by mouth once a day for twelve weeks.

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chicago